
Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning
Oncology Today with Dr Neil Love
00:00
Is There a Risk of a Class Not Approved?
A lot of these other by-specific therapies may have required hospitalization but over time did the label come out requiring hospitalization well to my knowledge most of the twos map didn't right you know. So speaking of my alum I see I birdamied here being looked at with lymphoma that's interesting. It is often hard to figure out and you know to be quite honest you know the investigators don't get a sip at the table when those discussions are happening around whether or not they need to be in clinical realm. We feel that people need to need to be or not we had we may help inform the guidelines on the back end but I'm not sure we're sitting there planning
Transcript
Play full episode